目的:本系统综述旨在总结社会心理干预对乳腺癌女性身体形象的可行性和可接受性的证据,以及用于评估相关干预措施的研究方法。
方法:文章通过MEDLINE鉴定,CINAHL,中部,心理信息,和EMBASE。纳入标准是:(1)从2000年开始的英文同行评审出版物,全文可访问,(2)关于心理社会干预和/或研究方法的可行性和/或可接受性的报告数据,(3)包括至少一个身体形象的测量或报告的与身体有关的主题,和(4)样本包括被诊断患有乳腺癌的女性。所有研究设计均合格。两名评审员独立进行研究选择,数据提取,和质量评估。
结果:共纳入62篇。参与者和比较组的干预措施也各不相同。干预措施和研究方法的可行性和可接受性在研究中的操作和报告不一致。可行性和可接受性的证据在研究内部和研究之间是不同的,虽然大多是积极的。
结论:发表的关于身体形象和研究方法的心理社会干预措施通常是可行和可接受的。研究结果应用于推进发展,实施,和评估旨在改善诊断为乳腺癌的妇女的预后(身体形象或其他方面)的干预措施。
背景:本评论已在国际前瞻性系统评论注册(PROSPERO;ID:CRD42021269062,2021年9月11日)。
OBJECTIVE: This systematic review aimed to summarize evidence for the feasibility and acceptability of psychosocial interventions for body image among women diagnosed with breast cancer and the
study methods used to evaluate the interventions in question.
METHODS: Articles were identified via MEDLINE, CINAHL, CENTRAL, PsychINFO, and EMBASE. Inclusion criteria were: (1) peer-reviewed publication in English from 2000 onward with accessible full-text, (2) reported data on the feasibility and/or acceptability of psychosocial interventions and/or study methods, (3) included at least one measure of body image or reported a body-related theme, and (4) sample comprised women diagnosed with breast cancer. All
study designs were eligible. Two reviewers independently performed
study selection, data extraction, and quality assessment.
RESULTS: Sixty-two articles were included. Participants and comparator groups varied as did interventions. Feasibility and acceptability of the interventions and
study methods were inconsistently operationalized and reported across studies. Evidence of feasibility and acceptability was heterogeneous within and across studies, though mostly positive.
CONCLUSIONS: Published psychosocial interventions for body image and
study methods are generally feasible and acceptable. Findings should be used to advance the development, implementation, and evaluation of interventions designed to improve outcomes (body image or otherwise) for women diagnosed with breast cancer.
BACKGROUND: This review was registered with the International Prospective Register of Systematic Reviews (PROSPERO; ID: CRD42021269062, 11 September 2021).